Compare XSLL & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XSLL | EIKN |
|---|---|---|
| Founded | 2025 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.8M | 316.3M |
| IPO Year | 2025 | 2026 |
| Metric | XSLL | EIKN |
|---|---|---|
| Price | $10.05 | $4.80 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 39.4K | ★ 511.7K |
| Earning Date | N/A | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.80 | $4.72 |
| 52 Week High | $10.05 | $16.50 |
| Indicator | XSLL | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 65.53 | 33.10 |
| Support Level | $9.99 | N/A |
| Resistance Level | N/A | $6.82 |
| Average True Range (ATR) | 0.01 | 0.63 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 100.00 | 3.10 |
Xsolla SPAC 1 is a blank check company.
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.